Coronavirus Disease-2019 환자 치료에 대한 중의 RCT 연구 동향
A Review of Randomized Controlled Trials of Traditional Chinese Medicine Treatment for Coronavirus Disease 2019 Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The purpose of this study is to investigate recent trends in randomized controlled trials (RCTs) on the treatment of Coronavirus disease 2019 (COVID-19) patients with traditional Chinese medicine (TCM) and analyze the results for the activation of COVID-19 Korean medicine research. Methods: We searched for RCTs published from December 2019 to October 2021 in the Chinese National Knowledge Infrastructure Database (CNKI). The investigation focused on the type of study, the purpose of the study, and the treatment methods. Results: A total of 8 RCTs were selected and analyzed from the 447 searched studies. All studies attempted to observe the effects of herbal medicine. Herbal medicine included granules, decoctions, and intravenous injections. The most frequently used herb type was drugs for clearing away heat and detoxification and releasing the exterior syndrome. In most studies, the effectiveness of TCM treatment of COVID-19 was significantly high. Conclusions: Although more quality studies are needed to support these results, TCM treatment for COVID-19 has been effective. Therefore, we hope that Korean medicine studies on infectious diseases will be actively conducted like TCM and contribute to national health.
Abstract
Objectives: The purpose of this study is to investigate recent trends in randomized controlled trials (RCTs) on the treatment of Coronavirus disease 2019 (COVID-19) patients with traditional Chinese medicine (TCM) and analyze the results for the activation of COVID-19 Korean medicine research. Methods: We searched for RCTs published from December 2019 to October 2021 in the Chinese National Knowledge Infrastructure Database (CNKI). The investigation focused on the type of study, the purpose of the study, and the treatment methods. Results: A total of 8 RCTs were selected and analyzed from the 447 searched studies. All studies attempted to observe the effects of herbal medicine. Herbal medicine included granules, decoctions, and intravenous injections. The most frequently used herb type was drugs for clearing away heat and detoxification and releasing the exterior syndrome. In most studies, the effectiveness of TCM treatment of COVID-19 was significantly high. Conclusions: Although more quality studies are needed to support these results, TCM treatment for COVID-19 has been effective. Therefore, we hope that Korean medicine studies on infectious diseases will be actively conducted like TCM and contribute to national health.
참고문헌 (33)
- 중앙방역대책본부, "코로나바이러스감염증-19 대응 지침(지자체용). 제10-1판", 질병관리청, 95~105 (2021)
- 중앙방역대책본부, "코로나19 국내예방접종완료자 관리 지침. 제3판", 질병관리청, ~ (2021)
- 中华人民共和国国家卫生健康委员会, "新型冠状病毒肺炎诊疗方案第八版", 中华人民共和国国家卫生健康委员会, ~ (2021)
- Yang M, "Systematic Review on the Treatment of Novel Coronavirus Pneumonia with Chinese Herbal Lianhua Qingwen", Chinese Journal of Drug Evaluation, 37(2), pp.126~130 (2020)
- Zhang H, "Meta analysis and trial sequential analysis of Lianhua Qingwen treating COVID-19", Prac J Med ＆Pharm, 37(12), pp.1110~1114 (2020)
- Zhang Lh, "Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19 : A national retrospective registry study", Phytomedicine, 85, pp.153531~ (2021)
- Shuang Z, "Traditional Chinese medicine shenhuang granule in patients with severe", critical COVID-19 : A randomized controlled multicenter trial, 2021, pp.89, 153612~
- XinYi Z, "Efficacy and safety of Xiyanping injection in the treatment of COVID-19 : A multicenter, prospective, open-label and randomized controlled trial", Phytotherapy research, 35(8), pp.4401~4410 (2021)
- Xiaolong X, "Efficacy and safety of Reduning injection in the treatment of COVID-19 : a randomized, multicenter clinical study", Annals of palliative medicine, 10(5), pp.5146~5155 (2021)
- Hu F, "Jinyinhua Liquid(金银花口服液)at Different Dosage Combined with Western Medicine Conventional Treatment for Common Type COVID-19 : A Multicenter Trial of 187 Cases", Journal of Traditional Chinese Medicine, 62(6), pp.510~515 (2021)
- Zhijian L, "The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19 : A prospective randomized controlled trial", European Journal of Integrative Medicine, 42, pp.101305~ (2021)
- Jin W, "The Efficacy of Ｒecommended Treatments with Integrated Chinese and Western Medicine on Coronavirus Disease 2019(COVID-19)in Sichuan : A Clinical Trial Observation", Pharmacology and Clinics of Chinese Materia Medica, 36(6), pp.6~10 (2020)
- Zhang Y, "Clinical Efficacy of Jinyinhua Oral Liquid in the Treatment of 80 Patients with Coronavirus Disease 2019", China Pharmaceuticals, 29(09), pp.23~26 (2020)
- Sun H, "Study on Clinical Efficacy of Lianhua Qingke Granule in Treatment of Mild and Ordinary COVID-19", Chinese Journal of Experimental Traditional Medical Formulae, 26(14), pp.29~34 (2020)
- 식품의약품안전처 의약품정책과, "코로나19 치료제⋅백신 임상시험 등 진행현황", 질병관리본부, ~ (2020)
- Pang W, "Chinese medical drugs for coronavirus disease 2019 : A systematic review and metaanalysis", Integrative Medicine Research, 9(3), pp.100477~ (2020)
- 이경은, "코로나-19 환자의 후유증 한약 치료에 대한 고찰", 대한한방내과학회지, 42(1), pp.53~66 (2021), 대한한방내과학회[DOI]
- 정선형, "코로나-19 무증상 감염 환자의 한약 치료 방안에 대한 고찰", 대한한의학회지, 42(1), pp.99~109 (2021), 대한한의학회[DOI]
- 강보형, "COVID-19에 대한 청폐배독탕의 연구 동향 분석", 대한한방내과학회지, 41(3), pp.424~433 (2020), 대한한방내과학회[DOI]
- Shi H, "Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study", Evidence-Based Complementary and Alternative Medicine, pp.4510591~ (2019)
- Jin Z, "Structure of Mpro from SARS-CoV-2and discovery of its inhibitors", Nature, 582, pp.289~293 (2020)
- Enmozhi SK, "Andrographolide as a potential inhibitor of SARS-CoV-2 main protease : an in silico approach", Journal of Biomolecular Structure and Dynamics, 39(9), pp.3092~3098 (2021)
- Fuzimoto AD, "An overview of the anti-SARS-CoV-2properties of Artemisia annua, itsantiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment", Journal of Integrative Medicine (2021)[DOI]
- Liu M, "Antiviral activities of Lonicera japonica Thunb. Components against grouper iridovirus in vitro and in vivo", Aquaculture, 519, pp.734882~ (2020)
- Guo S, "Antiviral activity of iridoid glycosides extracted from Fructus Gardeniae against influenza A virus by PACT-dependent suppression of viral RNA replication", Scientific Reports, 10(1), pp.1897~ (2020)
- Xu Z, "Pathological findings of COVID-19 associated with acute respiratory distress syndrome", The Lancet Respitory Medicine, 8(4), pp.420~422 (2020)
- Qin C, "Dysregulation of Immune Response in Patients With Coronavirus 2019(COVID-19)in Wuhan, China", Infectious Disease Society of America, 71(15), pp.762~768 (2020)
- Hu B, "The cytokine storm and COVID-19", Journal of Medical Virology, 93(1), pp.250~256 (2020)
- Tanaka T, "Immunotherapeutic implications of IL-6 blockade for cytokine storm", Immunotherapy, 8(8), pp.959~970 (2016)
- 唐陆平, "金银花提取物改善脂多糖致大鼠急性肺损伤作用机制研究", Livestock and Poultry Industry, 10, pp.1~3 (2019)
- Sun Y, "Qingfei Paidu Decoction(清肺排毒汤)for Treatment of Mild", Moderate COVID-19in 295 Cases : A Multi-Centered, 2021, pp.62(7), 599~603
- Zhang P, "Clinical Study on the Improvement of Inflammatory Cytokines in Critically Ill Patients with COVID-19 Treated by Qingfei Paidu Decoction", Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology, 23(2), pp.391~395 (2021)
- 이가현, "코로나19 치료제의 현황 및 유효성, 안전성", Journal of Korean Society of Health-System Pharmacists, 38(3), pp.377~391 (2021)